Form 4 for DGX Quest Diagnostics
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001022079-25-000090 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-05 | 2025-03-04 | DGX | Davis J. E. | CEO, Pres, Dir | A - Grant | $173.74 | +61.9K | 198.5K | +45% | +$10.76M | |
| M | 2025-03-05 | 2025-03-03+ | DGX | Davis J. E. | CEO, Pres, Dir | F - Tax | $173.74 | -33.3K | 166.8K | -17% | -$5.79M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-04 | A | A | 61,917 | $173.74 | 198,470 | D | — | — | (F2) Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock awards approved in accordance with the requirements of Rule 16b-3(d). |
| 2 | Common | Common Stock | 2025-03-03 | F | D | 1,662 | $173.74 | 136,553 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |
| 3 | Common | Common Stock | 2025-03-04 | F | D | 31,656 | $173.74 | 166,814 | D | — | — | (F3) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock awards. |